{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:48:44Z","timestamp":1767649724674},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T00:00:00Z","timestamp":1562716800000},"content-version":"vor","delay-in-days":6948,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ackdjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Renal Replacement Therapy"],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1053\/jarr.2000.8120","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T03:46:10Z","timestamp":1030247170000},"page":"210-219","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cardiac Complications of End-Stage Renal Disease"],"prefix":"10.1053","volume":"7","author":[{"given":"Scott W.","family":"Burke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allen T.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/jarr.2000.8120_bib1","series-title":"United States Renal Data Survey: 1999 Annual Data Report","year":"1999"},{"key":"10.1053\/jarr.2000.8120_bib2","first-page":"831","article-title":"Controlling the epidemic of cardiovascular disease in chronic renal disease: Report from the National Kidney Foundation Task Force on Cardiovascular Disease","volume":"9","author":"Meyer","year":"1998","journal-title":"J Am Soc Nephol"},{"key":"10.1053\/jarr.2000.8120_bib3","first-page":"S16","article-title":"Epidemiology of cardiovascular disease in chronic renal disease","volume":"9","author":"Foley","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2000.8120_bib4","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/ajkd.1998.v32.pm9820463","article-title":"Controlling the epidemic of cardiovascular disease in chronic renal disease: Where do we start?","volume":"32","author":"Levey","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2000.8120_bib5","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/ndt\/12.6.1187","article-title":"Relevance of conventional cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients on renal replacement therapy","volume":"12","author":"Koch","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2000.8120_bib6","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJM199809173391203","article-title":"Poor long-term survival after acute myocardial infarction among patients on long-term dialysis","volume":"339","author":"Herzog","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/jarr.2000.8120_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0272-6386(12)80827-4","article-title":"Cardiovascular risk factors in chronic renal failure and hemodialysis populations","volume":"19","author":"Ma","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2000.8120_bib8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000187353","article-title":"Serum lipids predict cardiac death in diabetic patients on maintenance hemodialysis","volume":"64","author":"Tschope","year":"1993","journal-title":"Nephron"},{"key":"10.1053\/jarr.2000.8120_bib9","first-page":"S24","article-title":"Epidemiology of cardiovascular risk factors in chronic renal disease","volume":"9","author":"Coresh","year":"1998","journal-title":"J Am Soc Nephrol"},{"issue":"suppl","key":"10.1053\/jarr.2000.8120_bib10","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1046\/j.1523-1755.1999.07164.x","article-title":"Lipoprotein (a) as a risk factor for coronary artery disease in hemodialysis patients","volume":"71","author":"Ohashi","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2000.8120_bib11","first-page":"266","article-title":"Is an elevated level of serum lipoprotein (a) a risk factor for cardiovascular disease in CAPD patients?","volume":"12","author":"Avram","year":"1996","journal-title":"Adv Perit Dial"},{"key":"10.1053\/jarr.2000.8120_bib12","first-page":"9","article-title":"Prognosis for patients with angina pectoris accompanied by chronic renal failure","volume":"34","author":"Suto","year":"1999","journal-title":"J Cardiol"},{"key":"10.1053\/jarr.2000.8120_bib13","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/ki.1996.201","article-title":"Outcome and risk factors of ischemic heart disease in chronic uremia","volume":"49","author":"Parfrey","year":"1996","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2000.8120_bib14","first-page":"239","article-title":"Cardiovascular disease and mortality in ESRD","volume":"11","author":"Foley","year":"1998","journal-title":"J Nephrol"},{"key":"10.1053\/jarr.2000.8120_bib15","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1681\/ASN.V8121889","article-title":"Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients","volume":"8","author":"Koch","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2000.8120_bib16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/01.CIR.97.2.138","article-title":"Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease","volume":"97","author":"Moustapha","year":"1998","journal-title":"Circulation"},{"key":"10.1053\/jarr.2000.8120_bib17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0272-6386(96)90523-5","article-title":"Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients","volume":"27","author":"Tomura","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2000.8120_bib18","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1681\/ASN.V1051027","article-title":"The low molecular weight phenotype is an independent predictor for coronary artery disease in hemodialysis patients: A prospective follow-up","volume":"10","author":"Kronenberg","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2000.8120_bib19","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/hrt.81.2.134","article-title":"Monocyte expression of tissue factor and adhesion molecules: The link with accelerated coronary artery disease in patients with chronic renal failure","volume":"81","author":"Al-Saady","year":"1999","journal-title":"Heart"},{"key":"10.1053\/jarr.2000.8120_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0272-6386(99)70251-9","article-title":"Relationship of dialysis membrane and cause-specific mortality","volume":"33","author":"Bloembergen","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2000.8120_bib21","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJM199810083391507","article-title":"Care of patients undergoing hemodialysis","volume":"339","author":"Ifudu","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/jarr.2000.8120_bib22","first-page":"221","article-title":"Serum enzyme assays in the diagnosis of acute myocardial infarction","volume":"105","author":"Lee","year":"1986","journal-title":"Recommendations based on a quantitative analysis. Ann Intern Med"},{"key":"10.1053\/jarr.2000.8120_bib23","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/14.8.1948","article-title":"Increased cardiac troponin T and endothelin-1 concentrations in dialysis patients may indicate heart disease","volume":"14","author":"Lowbeer","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2000.8120_bib24","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/clinchem\/44.7.1410","article-title":"Cardiac troponin T in hemodialyzed patients","volume":"44","author":"Ooi","year":"1998","journal-title":"Clin Chem"},{"key":"10.1053\/jarr.2000.8120_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000006859","article-title":"Specificity of cardiac troponin I and creatine kinase-MB isoenzyme in asymptomatic long-term hemodialysis patients and the effect of hemodialysis on these cardiac markers","volume":"90","author":"Tun","year":"1998","journal-title":"Cardiology"},{"key":"10.1053\/jarr.2000.8120_bib26","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0735-1097(99)00207-7","article-title":"A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a Veteran's Hospital: A pilot study","volume":"34","author":"Roppolo","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/jarr.2000.8120_bib27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1523-1755.1998.00988.x","article-title":"Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients","volume":"54","author":"Dahan","year":"1998","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2000.8120_bib28","first-page":"1121","article-title":"Diagnostic value of myocardial thallium stress scintigraphy in the detection of coronary artery disease in patients undergoing chronic hemodialysis","volume":"88","author":"Dahan","year":"1995","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1053\/jarr.2000.8120_bib29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/000331979104200407","article-title":"Assessment of coronary artery disease by thallium scan in type-1 diabetic uremic patients awaiting combined pancreas and renal transplantation","volume":"42","author":"Trochu","year":"1991","journal-title":"Angiology"},{"key":"10.1053\/jarr.2000.8120_bib30","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0002-9149(99)80658-4","article-title":"Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease","volume":"75","author":"Reis","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1053\/jarr.2000.8120_bib31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0733-8651(18)30049-3","article-title":"Cardiac disease in patients with end-stage renal disease","volume":"13","author":"Staffeld","year":"1995","journal-title":"Cardiol Clin"},{"key":"10.1053\/jarr.2000.8120_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"The Heart Outcomes Prevention Evaluation Study Investigators: Effects of an angiotensin-convertingenzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/jarr.2000.8120_bib33","series-title":"Principles and Practice of Dialysis","first-page":"246","article-title":"Dyslipidemias of end-stage renal disease","author":"Toto","year":"1994"},{"key":"10.1053\/jarr.2000.8120_bib34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1525-139X.1994.tb00815.x","article-title":"Coronary artery bypass graft surgery in end-stage renal disease: Indications, contraindications, and uncertainties","volume":"7","author":"Rutsky","year":"1995","journal-title":"Semin Dial"},{"key":"10.1053\/jarr.2000.8120_bib35","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0002-8703(05)80268-6","article-title":"Shortand long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients","volume":"110","author":"Kahn","year":"1990","journal-title":"Am Heart J"},{"key":"10.1053\/jarr.2000.8120_bib36","article-title":"Does contemporary percutaneous coronary intervention improve the otherwise dismal prognosis of patients with end-stage renal disease on dialysis?","volume":"100","author":"Gruberg","year":"1999","journal-title":"Circulation"},{"key":"10.1053\/jarr.2000.8120_bib37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0002-8703(94)90476-6","article-title":"Complications and long-term outcome after percutaneous angioplasty in chronic hemodialysis patients","volume":"128","author":"Ahmed","year":"1994","journal-title":"Am Heart J"},{"key":"10.1053\/jarr.2000.8120_bib38","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0002-9149(98)00347-6","article-title":"Effectiveness of percutaneous interventions to prevent recurrent coronary events in patients on chronic hemodialysis","volume":"82","author":"Marso","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1053\/jarr.2000.8120_bib39","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1523-1755.1999.00540.x","article-title":"Long-term outcome of dialysis patients in the United States with coronary revascularization procedures","volume":"56","author":"Herzog","year":"1999","journal-title":"Kidney Int"},{"key":"10.1053\/jarr.2000.8120_bib40","first-page":"38","article-title":"Efficacy of percutaneous transluminal coronary angioplasty for patients on hemodialysis","volume":"19","author":"Sanai","year":"1999","journal-title":"Comparison with those not on dialysis. Am J Nephrol"},{"issue":"1917","key":"10.1053\/jarr.2000.8120_bib41","article-title":"Outcome of coronary stenting in patients with end-stage renal disease","volume":"100","author":"Azar","year":"1999","journal-title":"Circulation"},{"key":"10.1053\/jarr.2000.8120_bib42","first-page":"1919","article-title":"Percutaneous coronary revascularization in patients with mild versus severe renal failure","volume":"100","author":"Rubenstein","year":"1999","journal-title":"Circulation"},{"key":"10.1053\/jarr.2000.8120_bib43","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/0003-4975(94)91671-3","article-title":"Coronary artery bypass grafting in patients with dialysisdependent renal failure","volume":"58","author":"Owen","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/jarr.2000.8120_bib44","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0967-2109(98)00036-2","article-title":"A comparison of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in patients on hemodialysis","volume":"6","author":"Simsir","year":"1998","journal-title":"Cardiovasc Surg"},{"key":"10.1053\/jarr.2000.8120_bib45","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S1010-7940(99)00097-4","article-title":"Early and long-term results of coronary artery bypass grafts in patients with dialysis dependent renal failure","volume":"15","author":"Labrousse","year":"1999","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/jarr.2000.8120_bib46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJM199607253350401","article-title":"Comparison of coronary bypass surgery with multivessel disease","volume":"335","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/jarr.2000.8120_bib47","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/ndt\/14.3.771","article-title":"Does intensive perioperative dialysis improve the results of coronary artery bypass grafting in hemodialyzed patients?","volume":"33","author":"Okada","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2000.8120_bib48","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1681\/ASN.V212","article-title":"The natural history of myocardial disease in dialysis patients","volume":"2","author":"Parfrey","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2000.8120_bib49","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/ndt\/11.7.1277","article-title":"Outcome and risk factors for left ventricular disorders in chronic uremia","volume":"11","author":"Parfrey","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2000.8120_bib50","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1681\/ASN.V75728","article-title":"Hypoalbuminemia, cardiac morbidity, and mortality in end-stage renal disease","volume":"7","author":"Foley","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/jarr.2000.8120_bib51","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/ndt\/13.6.1518","article-title":"Use of the Valsalva maneuver to identify hemodialysis patients at risk of congestive heart failure","volume":"13","author":"Van Kraaij","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2000.8120_bib52","series-title":"Principles and Practice of Dialysis","first-page":"170","article-title":"Left ventricular dysfunction in dialysis subjects","author":"Harnett","year":"1994"},{"key":"10.1053\/jarr.2000.8120_bib53","first-page":"308","article-title":"Echocardiographic evaluation in long-term continuous ambulatory peritoneal dialysis compared with the hemodialysis patients","volume":"49","author":"Takeda","year":"1998","journal-title":"Clin Nephrol"},{"key":"10.1053\/jarr.2000.8120_bib54","first-page":"107","article-title":"Gender differences in mediators of left ventricular hypertrophy in dialysis patients","volume":"49","author":"Savage","year":"1998","journal-title":"Clin Nephrol"},{"key":"10.1053\/jarr.2000.8120_bib55","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CRXL in congestive heart failure: Metoprolol CRXL randomised intervention trial in congestive heart failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/jarr.2000.8120_bib56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The cardiac insufficiency bisoprolol study II (CIBIS-II) : A randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/jarr.2000.8120_bib57","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"issue":"suppl","key":"10.1053\/jarr.2000.8120_bib58","first-page":"S56","article-title":"Treatment of renal anemia by erythropoetin substitution: The effects on the cardiovascular system","volume":"44","author":"Radermacher","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1053\/jarr.2000.8120_bib59","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/jarr.2000.8120_bib60","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/ndt\/14.suppl_2.75","article-title":"Normalization of hemoglobin: Why not?","volume":"14","author":"Jacobs","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2000.8120_bib61","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/ndt\/13.5.1206","article-title":"High dose enalapril impairs the response to erythropoetin treatment in dialysis patients","volume":"13","author":"Albitar","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/jarr.2000.8120_bib62","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0272-6386(95)90552-9","article-title":"Continuous ambulatory peritoneal dialysis for patients with severe left ventricular systolic dysfunction and endstage renal disease","volume":"25","author":"Hebert","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/jarr.2000.8120_bib63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/089686089501500102","article-title":"Continuous ambulatory peritoneal dialysis and the heart","volume":"15","author":"Alpert","year":"1995","journal-title":"Perit Dial Int"},{"key":"10.1053\/jarr.2000.8120_bib64","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1093\/qjmed\/89.9.681","article-title":"Long-term successful management of refractory congestive cardiac failure by intermittent ambulatory peritoneal ultrafiltration","volume":"89","author":"Tormey V Conlon","year":"1996","journal-title":"QJM"},{"key":"10.1053\/jarr.2000.8120_bib65","first-page":"505","article-title":"Echocardiographic assessment of left ventricular hypertrophy, diastolic dysfunction and pericardial disease in patients on maintenance hemodialysis","volume":"73","author":"Hakim","year":"1996","journal-title":"East Afr Med J"},{"key":"10.1053\/jarr.2000.8120_bib66","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0733-8651(18)30342-4","article-title":"Pericarditis in end-stage renal disease","volume":"8","author":"Rostand","year":"1990","journal-title":"Cardiol Clin"},{"key":"10.1053\/jarr.2000.8120_bib67","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0272-6386(96)90100-6","article-title":"Subxiphoid pericardial window for pericardial effusion in endstage renal disease","volume":"27","author":"Figueroa","year":"1996","journal-title":"Am J Kidney Dis"}],"container-title":["Advances in Renal Replacement Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1073444900700136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1073444900700136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T08:06:50Z","timestamp":1702454810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1073444900700136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["S1073444900700136"],"URL":"https:\/\/doi.org\/10.1053\/jarr.2000.8120","relation":{},"ISSN":["1073-4449"],"issn-type":[{"value":"1073-4449","type":"print"}],"subject":[],"published":{"date-parts":[[2000,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac Complications of End-Stage Renal Disease","name":"articletitle","label":"Article Title"},{"value":"Advances in Renal Replacement Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/jarr.2000.8120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 National Kidney Foundation, Inc. All rights reserved. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}